Upregulation of drug uptake SLC transporters or downregulation of drug efflux ABC transporters are promising targets in GEM treatment of pancreatic cancer, but the later is more common strategy to overcome drug resistance. This evidence concerns the gene ABCG2 and pancreatic neoplasm.